{"gene":"GDF9","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2003,"finding":"GCNF (germ cell nuclear factor) directly represses GDF9 transcription by binding to DR0 elements within the GDF9 gene promoter, as shown by molecular binding studies and reporter assays in an oocyte-specific GCNF knockout mouse model.","method":"Chromatin binding assays, reporter gene assays, oocyte-specific conditional knockout mouse model","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal molecular binding to promoter DR0 elements confirmed by reporter assays and in vivo knockout model with defined phenotype","pmids":["12912906"],"is_preprint":false},{"year":2006,"finding":"NOBOX transcription factor directly binds to specific NOBOX binding elements (NBEs: TAATTG, TAGTTG, TAATTA) in the Gdf9 promoter at positions -786, -967, and -1259, and augments transcriptional activity of Gdf9 in oocytes during early folliculogenesis, as confirmed by chromatin immunoprecipitation.","method":"SELEX (cyclic amplification of sequence target assay), mutation analysis, luciferase reporter assays, chromatin immunoprecipitation (ChIP)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods including SELEX, mutation analysis, reporter assays, and ChIP all confirming direct NOBOX binding and transcriptional activation of GDF9","pmids":["16997917"],"is_preprint":false},{"year":2007,"finding":"GDF9 stimulates proliferation and inhibits steroidogenesis in bovine theca cells from small (3-6 mm) follicles, decreasing progesterone and androstenedione production, and activates SMAD2/3-mediated CAGA promoter signaling via ALK5 (TGFBR1); theca cells from large follicles show little response, correlated with lower ALK5 mRNA abundance.","method":"Primary bovine theca cell culture, [3H]-thymidine incorporation, steroid RIA, transfected SMAD reporter assay, RT-PCR","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (proliferation assay, steroid measurement, SMAD reporter, mRNA quantification) in primary cells with dose-response","pmids":["17959852"],"is_preprint":false},{"year":2007,"finding":"BMP15 and GDF9 together (but not alone) control cumulus cell cholesterol biosynthesis by promoting expression of cholesterol biosynthetic enzyme transcripts (Mvk, Pmvk, Fdps, Sqle, Cyp51, Sc4mol, Ebp); oocytes are deficient in cholesterol synthesis and depend on cumulus cells for cholesterol supply via GDF9/BMP15 paracrine signaling.","method":"Bmp15−/− and Bmp15−/−Gdf9+/− double mutant mouse models, oocytectomy, wild-type oocyte co-culture rescue experiments, de novo cholesterol synthesis assays, transcript analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in multiple mutant combinations with oocytectomy rescue and biochemical cholesterol synthesis measurement","pmids":["18045843"],"is_preprint":false},{"year":2008,"finding":"Recombinant mouse GDF9 is secreted as a dimer of mature protein (in both the presence and absence of BMP15), while BMP15 proregion noncovalently interacts with GDF9 mature protein (co-immunoprecipitation), forming heteromeric BMP15/GDF9 complexes; these cooperative interactions are species-specific and dependent on the BMP15 proregion, and signal through BMPR2 and ACVR1B/TGFBR1/ACVR1C receptor pathways.","method":"Co-immunoprecipitation, Western blot under non-reducing conditions, rat granulosa cell [3H]-thymidine incorporation bioassay, immunoneutralization experiments","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, receptor pathway inhibition, species-specificity tested with immunoneutralization in bioassay, multiple orthogonal methods","pmids":["18633140"],"is_preprint":false},{"year":2011,"finding":"Purified mature GDF9 and BMP15 synergistically stimulate granulosa cell DNA synthesis and SMAD3 signaling; this synergy is specific (neither can be replaced by analogous TGF-β family members) and is dependent on SMAD2/3 phosphorylation, ERK1/2 (MAPK), and SRC kinase signaling pathways, but not NF-κB.","method":"Primary murine granulosa cell culture, [3H]-thymidine incorporation, SMAD3 transcriptional reporter assay, pharmacological inhibitors (SB431542, MEK/ERK inhibitor, SRC inhibitor, NF-κB inhibitor)","journal":"Molecular human reproduction","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reconstituted with purified mature proteins, multiple pathway inhibitors, specificity testing with related ligands, multiple orthogonal readouts","pmids":["21911477"],"is_preprint":false},{"year":2011,"finding":"GDF9 and BMP15 synergistically activate Smad2/3 and PI3K/Akt pathways in granulosa cells to induce AMH/Amh expression by recruiting the coactivator p300 to the AMH promoter, promoting H3K27 acetylation; FSH antagonizes this via PKA/SF1-mediated induction of GIOT-1, which recruits HDAC2 to deacetylate H3K27ac and suppress AMH expression.","method":"Primary mouse granulosa cell and KGN cell line experiments, chromatin immunoprecipitation (ChIP) for p300 and H3K27ac, siRNA knockdown, Fshβ-null mouse model with FSHβ transgenic rescue, in vivo serum AMH measurement","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP with multiple histone marks, siRNA, genetic mouse models with transgenic rescue, multiple orthogonal methods in vitro and in vivo","pmids":["30060157"],"is_preprint":false},{"year":2011,"finding":"Immunization of mice against the full-length GDF9 proregion increases ovulation rate (more corpora lutea) but also decreases litter size, suggesting the GDF9 proregion plays a physiologically important role in regulating ovulation rate and litter size in vivo after secretion.","method":"Active immunization of mice with GDF9 proregion peptide-KLH conjugates, ovarian histology (corpora lutea count), litter size counts","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo functional endpoint with antibody-based inhibition, single lab, two quantitative readouts","pmids":["22106408"],"is_preprint":false},{"year":2011,"finding":"Ovine and murine GDF9+BMP15 cooperatively stimulate granulosa cell [3H]-thymidine uptake through SMAD2/3 signaling (required for both species); ovine GDF9+BMP15 also requires NF-κB and partially p38-MAPK; murine GDF9+BMP15 requires ERK-MAPK; neither requires SMAD1/5/8 pathway. Species-specific differences in non-SMAD signaling correlate with differences in molecular complex forms detected by Western blot.","method":"Rat granulosa cell [3H]-thymidine incorporation, pharmacological pathway inhibitors, Western blot analysis of molecular complexes","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pathway inhibitors tested systematically, Western blot for molecular forms, single lab","pmids":["21474603"],"is_preprint":false},{"year":2012,"finding":"Human GDF9 (hGDF9) is secreted in a latent form, whereas mouse GDF9 is active; a single residue, Gly391 in the mature domain of hGDF9 (part of the type I receptor binding site), confers latency by reducing receptor affinity. Substituting Gly391 with Arg (as in mouse GDF9) activates hGDF9 to levels comparable to mGDF9 in both adrenocortical cell luciferase assay and granulosa cell proliferation assay.","method":"Site-directed mutagenesis, adrenocortical cell luciferase reporter assay, murine granulosa cell proliferation assay, dose-response curves (EC50)","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed mutagenesis with functional validation in two independent cell-based assays, identifies single causative residue","pmids":["22234469"],"is_preprint":false},{"year":2012,"finding":"GDF9 upregulates NBL1 (DAN) mRNA expression in granulosa cells; DAN specifically antagonizes BMP2 and BMP4 signaling in granulosa cells, modulating their actions during folliculogenesis; GDF9 thus indirectly establishes a BMP antagonist gradient in granulosa cells.","method":"Granulosa cell culture with recombinant GDF9, RT-PCR for NBL1 expression, cell expression system bioassays with recombinant DAN against multiple TGF-β members, progesterone production assay with BMP4 ± DAN","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional cell culture experiments with recombinant proteins and downstream steroidogenesis readout, single lab","pmids":["22357543"],"is_preprint":false},{"year":2013,"finding":"The GDF9 p.R146C mutation (found in women with diminished ovarian reserve) reduces GDF9 mature protein secretion in cultured cells, decreases GDF9-stimulated granulosa cell proliferation, and impairs activation of the Smad2 pathway; structural modeling predicts disruption of an α-helix in the GDF9 proregion.","method":"Site-directed mutagenesis and expression in cultured cells, Western blot for secreted mature protein, human granulosa cell proliferation assay, Smad2 phosphorylation assay, protein structure modeling","journal":"Human reproduction (Oxford, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays (protein secretion, proliferation, Smad2 phosphorylation) for same mutant, single lab","pmids":["23851219"],"is_preprint":false},{"year":2013,"finding":"In primary granulosa cells, GDF-9 (with Smad3) stimulates follistatin transcription; FOXL2 negatively regulates GDF-9-induced follistatin transcription; the granulosa cell tumor-associated mutant FOXL2C134W completely ablates GDF-9-induced follistatin expression. Both the Smad binding element and forkhead binding element in the follistatin promoter are required for GDF-9/Smad3 action.","method":"Primary granulosa cell transfection/reporter assays, siRNA knockdown of FOXL2, promoter mutation analysis","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with promoter mutations and siRNA knockdown in primary cells, single lab","pmids":["23567549"],"is_preprint":false},{"year":2013,"finding":"Deletion of Gdf9 from inhibin-null (Inha−/−) mice rescues initial granulosa cell/oocyte growth defects at early follicle stages in Inha−/− ovaries, normalizes granulosa-oocyte growth dynamics, and reduces levels of Inhbb (activin βB subunit) that are upregulated in Inha−/−. However, Gdf9 deletion enhances onset of pre-tumor lesions in young mice, indicating GDF9 has a sequential role: promoting defective folliculogenesis early but suppressing tumor initiation.","method":"Inha−/− Gdf9−/− double knockout mouse model, histological analysis of follicle stages, tumor assessment, gene expression analysis","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 2 / Strong — double knockout epistasis with defined follicular and tumor phenotypes, mechanistically separates GDF9's roles at different stages","pmids":["23446452"],"is_preprint":false},{"year":2014,"finding":"Oocyte-derived BMP15, but not GDF9, down-regulates connexin43 (Cx43) expression and decreases gap junction intercellular communication (GJIC) activity in human granulosa cells via Smad1/5/8 phosphorylation and a Smad4-dependent pathway (blocked by dorsomorphin, a BMP type I receptor inhibitor, and Smad4 siRNA). GDF9 did not affect Cx43 or GJIC.","method":"Human granulosa cell line (SVOG) and primary human granulosa-lutein cells, Cx43 mRNA/protein measurement, GJIC functional assay, siRNA knockdown of Smad4, pharmacological inhibition of BMP type I receptor","journal":"Molecular human reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway dissection with siRNA and pharmacological inhibitor, functional GJIC assay in primary and immortalized human cells, single lab","pmids":["24413384"],"is_preprint":false},{"year":2014,"finding":"Multiple human GDF9 prodomain mutations associated with premature ovarian failure (S186Y, V216M, T238A) result in activation of hGDF9 by reducing the affinity of the prodomain for mature hGDF9, allowing it to more readily signal. Two mutations found in mothers of dizygotic twins (P103S, P374L) completely abrogate GDF9 expression. These were identified by site-directed mutagenesis and in vitro granulosa cell proliferation bioassays.","method":"Site-directed mutagenesis, expression in HEK293T cells, Western blot for mature protein, in vitro granulosa cell proliferation bioassay, homology structural modeling","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — systematic mutagenesis of 14 variants with functional bioassay validation, mechanistic explanation from structural modeling, single lab but multiple orthogonal methods","pmids":["24438375"],"is_preprint":false},{"year":2017,"finding":"Multiple BMP15 mutations associated with primary ovarian insufficiency reduce mature BMP15 protein production, BMP15 activity on granulosa cells, or the synergistic activity of BMP15 with GDF9; three variants (R68W, F194S, N196K) specifically reduce BMP15/GDF9 synergy, suggesting the GDF9-BMP15 interaction is central to human ovarian physiology.","method":"Site-directed mutagenesis, expression assays for protein production, granulosa cell bioassays, GDF9/BMP15 synergy assays","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic functional characterization of 10 mutants, single lab with multiple assay types","pmids":["28359091"],"is_preprint":false},{"year":2017,"finding":"The major oocyte-secreted molecular forms of ovine and bovine BMP15 and GDF9 are cleaved and uncleaved monomeric promature proteins (not dimers or heterodimers under native conditions), as determined by Western blot with specific monoclonal antibodies under non-reducing, reducing, and cross-linking conditions; in silico modelling proposes monomeric forms interact with type II and type I receptors to initiate synergistic signaling.","method":"Western blot with monoclonal antibodies (non-reducing, reducing, reducing+cross-linking conditions), recombinant protein controls including cysteine mutants and heterodimer, isolated oocyte in vitro secretion, in silico structural modelling","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rigorous biochemical characterization with multiple antibodies and gel conditions on native oocyte secretions, single lab","pmids":["28733348"],"is_preprint":false},{"year":2010,"finding":"GDF9 promotes invasiveness of prostate cancer PC-3 cells and induces epithelial-mesenchymal transition (EMT) markers (SNAI1, RhoC, ROCK-1, N-cadherin upregulation; E-cadherin downregulation); this effect is dependent on ALK-5 (activin-like kinase 5) signaling, as demonstrated by ALK-5 inhibitor treatment.","method":"GDF9 overexpression, knockdown, and recombinant GDF9 protein treatment in PC-3 cells; invasion assay; gene expression analysis; ALK-5 inhibitor pharmacological experiment","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — three independent manipulations (OE, KD, recombinant protein) with pharmacological pathway validation in cancer cell line, single lab","pmids":["21116689"],"is_preprint":false},{"year":2010,"finding":"In zebrafish, recombinant Gdf9 suppresses amh expression and increases expression of activin beta subunits (inhbaa, inhbb) in somatic cells in vitro; vivo-morpholino knockdown of gdf9 causes male-skewed sex ratio, indicating GDF9 promotes oocyte/ovary differentiation partly through suppression of amh.","method":"Recombinant zebrafish Gdf9 treatment of gonadal cells in vitro, RT-qPCR gene expression, vivo-morpholino knockdown with sex ratio phenotype","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein functional assay plus morpholino in vivo knockdown, but in zebrafish model","pmids":["28203731"],"is_preprint":false},{"year":2011,"finding":"GDF9 and BMP15 (exogenously supplied) induce antrum-like structure formation by bovine granulosa cells in oocytectomized complexes, and the combination is more potent than either factor alone; GDF9+BMP15 suppresses fibroblast-like differentiation of granulosa cells after oocyte removal.","method":"Bovine oocyte-granulosa cell complex culture, oocytectomy, recombinant GDF9 and BMP15 treatment, morphological assessment","journal":"The Journal of reproduction and development","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional cell culture with recombinant proteins and oocytectomy model, morphological readout only, single lab","pmids":["30033985"],"is_preprint":false},{"year":2021,"finding":"GDF-9 reduces follicular apoptosis and promotes granulosa cell proliferation in ovine preantral follicles via the PI3K/Akt/FOXO3a pathway; LY294002 (PI3K inhibitor) blocks GDF-9-induced primordial follicle activation and reduces p-Akt immunostaining, while GDF-9 treatment maintains nuclear exclusion of p-FOXO3a.","method":"In vitro culture of ovine ovarian cortical slices with recombinant GDF-9, PI3K inhibitor (LY294002), immunohistochemistry for p-Akt and p-FOXO3a, apoptosis and proliferation assays","journal":"Reproductive sciences (Thousand Oaks, Calif.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway inhibition with two downstream signaling readouts, single lab","pmids":["33409876"],"is_preprint":false},{"year":2014,"finding":"A tandem duplication of 475 bp containing part of the GDF9 gene promoter region (including three NOBOX-binding elements and an E-box) was identified in a woman with primary ovarian insufficiency, suggesting that disruption of these regulatory elements in the GDF9 promoter is causative of POI.","method":"Array comparative genomic hybridization (CGH), PCR breakpoint characterization, MLPA probe development for confirmation","journal":"Human reproduction (Oxford, England)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — structural genomic finding without functional experiments confirming promoter activity change; authors note no functional experiments were performed","pmids":["24939957"],"is_preprint":false},{"year":2015,"finding":"A novel NOBOX isoform expressed in the human fetal ovary is capable of upregulating the GDF9 promoter in reporter assays; GDF9 protein is transiently expressed in oocytes before follicle formation during human fetal ovarian development.","method":"Immunohistochemistry in human fetal ovary sections, qRT-PCR, luciferase reporter assay with novel NOBOX isoform","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with novel identified NOBOX isoform plus localization immunohistochemistry in human tissue, single lab","pmids":["25790371"],"is_preprint":false},{"year":2022,"finding":"Native human pro-mature GDF9 (~47 kDa) and BMP15 (~43 kDa) are detected in human oocytes by Western blot; GDF9 and BMP15 are secreted by oocytes during IVM, with GDF9 concentrations ~10-fold higher than BMP15; concentrations of both GDF9 and BMP15 homodimers are significantly lower in spent media from MII oocytes than GV oocytes; BMPR2, SMAD3, and SMAD5 are upregulated in cumulus cells from MII oocytes, indicating active GDF9/BMP15 signaling during meiotic resumption.","method":"Western blot, immunofluorescence, ELISA of spent IVM media (GDF9, BMP15, heterodimer), RT-qPCR for signaling pathway genes in cumulus cells","journal":"Reproductive biology and endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Western blot, ELISA, qPCR), native human oocyte material, single lab","pmids":["35986324"],"is_preprint":false}],"current_model":"GDF9 is an oocyte-secreted TGF-β superfamily member that signals through ALK5 (TGFBR1)/SMAD2/3 pathways to drive granulosa and cumulus cell proliferation, cholesterol biosynthesis, and antrum formation; its transcription is directly regulated by NOBOX (activating) and GCNF (repressing) via promoter binding; human GDF9 is secreted as a latent promature monomer (rendered active by a single Gly391Arg substitution that increases receptor affinity), and its cooperative/synergistic signaling with BMP15 depends on SMAD3, ERK1/2, and SRC kinase pathways and involves non-covalent heteromeric interactions that are species-specific and influenced by the BMP15 proregion."},"narrative":{"mechanistic_narrative":"GDF9 is an oocyte-secreted TGF-β superfamily ligand that drives follicular somatic cell proliferation and differentiation through type I receptor ALK5 (TGFBR1) and SMAD2/3 signaling [PMID:17959852]. Its transcription is directly controlled at the oocyte promoter by opposing factors: NOBOX activates GDF9 by binding defined NOBOX-binding elements, while germ cell nuclear factor (GCNF) represses it through DR0 elements [PMID:16997917, PMID:12912906]. Acting cooperatively with the related oocyte ligand BMP15, GDF9 synergistically stimulates granulosa cell DNA synthesis and SMAD3 signaling in a manner dependent on SMAD2/3, ERK1/2 (MAPK), and SRC kinase pathways, with non-SMAD pathway requirements differing between species [PMID:21911477, PMID:21474603]. This GDF9/BMP15 paracrine axis programs cumulus cell metabolism — inducing cholesterol biosynthetic enzymes that supply the cholesterol-deficient oocyte — and orchestrates antrum formation and somatic gene expression including AMH, which it induces by recruiting p300 to the AMH promoter to deposit H3K27 acetylation [PMID:18045843, PMID:30033985, PMID:30060157]. GDF9 also shapes the follicular signaling environment by inducing the BMP antagonist NBL1/DAN and follistatin transcription, and promotes follicle survival through PI3K/Akt/FOXO3a signaling [PMID:22357543, PMID:23567549, PMID:33409876]. Human GDF9 is secreted as a latent promature protein whose activity is gated by the proregion's affinity for the mature domain; a single mature-domain residue (Gly391) confers latency, and substitution to Arg activates it [PMID:22234469, PMID:28733348]. The interaction between the prodomain and mature domain is central to human ovarian physiology: prodomain mutations that reduce this affinity activate GDF9, expression-abrogating variants associate with dizygotic twinning, and loss-of-function variants (e.g. p.R146C) cause premature ovarian failure and diminished ovarian reserve [PMID:24438375, PMID:23851219].","teleology":[{"year":2003,"claim":"Established how GDF9 transcription is restrained in oocytes, identifying GCNF as a direct repressor acting through promoter DR0 elements.","evidence":"Chromatin binding and reporter assays with an oocyte-specific GCNF conditional knockout mouse","pmids":["12912906"],"confidence":"High","gaps":["Does not establish the activating side of the promoter switch","Repression dynamics across follicle stages not resolved"]},{"year":2006,"claim":"Identified NOBOX as the direct transcriptional activator of Gdf9, defining the positive arm of oocyte-specific GDF9 promoter control during early folliculogenesis.","evidence":"SELEX, mutation analysis, luciferase reporter assays, and ChIP for NOBOX binding elements in the Gdf9 promoter","pmids":["16997917"],"confidence":"High","gaps":["Combinatorial logic with GCNF repression not directly tested","In vivo contribution of each NBE not dissected"]},{"year":2007,"claim":"Defined the GDF9 receptor/SMAD pathway and a cell-context-dependent response, showing GDF9 signals via ALK5/SMAD2/3 to drive theca cell proliferation while inhibiting steroidogenesis.","evidence":"Primary bovine theca cell proliferation and steroid assays, SMAD CAGA reporter, ALK5 mRNA correlation","pmids":["17959852"],"confidence":"High","gaps":["Mechanism linking ALK5 abundance to follicle-size-dependent responsiveness not resolved","Type II receptor identity not addressed here"]},{"year":2007,"claim":"Revealed a metabolic function for the oocyte ligands, showing GDF9 and BMP15 together program cumulus cells to synthesize cholesterol that the oocyte cannot make itself.","evidence":"Bmp15/Gdf9 mutant mouse models with oocytectomy rescue and de novo cholesterol synthesis assays","pmids":["18045843"],"confidence":"High","gaps":["Direct transcriptional mechanism on cholesterol enzyme genes not defined","Relative contribution of GDF9 vs BMP15 not separated"]},{"year":2008,"claim":"Characterized the molecular basis of GDF9/BMP15 cooperativity, showing heteromeric interactions involving the BMP15 proregion that are species-specific and signal through defined type II/type I receptors.","evidence":"Co-IP, non-reducing Western blot, granulosa cell bioassay, and immunoneutralization","pmids":["18633140"],"confidence":"High","gaps":["Stoichiometry of the active complex unresolved","Whether the complex is obligate for signaling not settled"]},{"year":2011,"claim":"Reconstituted the synergy with purified proteins and mapped its signaling requirements, establishing dependence on SMAD2/3, ERK1/2, and SRC but not NF-κB.","evidence":"Purified mature GDF9/BMP15 on murine granulosa cells with pathway-specific inhibitors and SMAD3 reporter","pmids":["21911477"],"confidence":"High","gaps":["How SRC and ERK integrate with SMAD output not mechanistically linked","Receptor complex composition driving non-SMAD arms not defined"]},{"year":2011,"claim":"Showed species-specific non-SMAD signaling requirements, with ovine GDF9+BMP15 requiring NF-κB/p38 and murine requiring ERK, correlating with distinct molecular complex forms.","evidence":"Rat granulosa cell bioassay with pathway inhibitors and Western blot of molecular forms","pmids":["21474603"],"confidence":"Medium","gaps":["Structural basis of species-specific complexes not resolved","Single lab, single readout"]},{"year":2011,"claim":"Connected GDF9/BMP15 signaling to chromatin regulation of AMH, showing induction via SMAD2/3 and PI3K/Akt with p300 recruitment and H3K27ac, antagonized by FSH.","evidence":"ChIP for p300 and H3K27ac, siRNA, and Fshβ-null mouse with transgenic rescue","pmids":["30060157"],"confidence":"High","gaps":["Direct SMAD binding to the AMH promoter not delineated here","GDF9-only versus synergistic contribution not separated"]},{"year":2011,"claim":"Demonstrated an in vivo regulatory role for the secreted GDF9 proregion in setting ovulation rate and litter size.","evidence":"Active immunization of mice against GDF9 proregion with corpora lutea and litter size counts","pmids":["22106408"],"confidence":"Medium","gaps":["Molecular mechanism by which proregion antibody alters signaling unclear","Single lab in vivo endpoint"]},{"year":2011,"claim":"Showed GDF9 induces antrum-like structures and suppresses fibroblast-like dedifferentiation of granulosa cells, most potently with BMP15.","evidence":"Bovine oocyte-granulosa complex culture with oocytectomy and recombinant ligands, morphological readout","pmids":["30033985"],"confidence":"Medium","gaps":["Molecular drivers of antrum formation not defined","Morphological readout only"]},{"year":2012,"claim":"Identified the molecular cause of human GDF9 latency, pinpointing Gly391 in the mature domain as the residue gating receptor affinity and activity.","evidence":"Site-directed mutagenesis with adrenocortical luciferase and granulosa proliferation assays, EC50 analysis","pmids":["22234469"],"confidence":"High","gaps":["Structural detail of the receptor binding interface not solved","Physiological mechanism that overcomes latency in vivo unknown"]},{"year":2012,"claim":"Placed GDF9 upstream of a BMP antagonist gradient, showing it upregulates NBL1/DAN which selectively antagonizes BMP2/BMP4 in granulosa cells.","evidence":"Granulosa cell culture with recombinant GDF9, RT-PCR, and DAN bioassays with steroidogenesis readout","pmids":["22357543"],"confidence":"Medium","gaps":["Direct transcriptional control of NBL1 by GDF9 not shown","In vivo relevance of the gradient untested"]},{"year":2013,"claim":"Defined GDF9/SMAD3 regulation of follistatin and its modulation by FOXL2, including ablation by the tumor-associated FOXL2C134W mutant.","evidence":"Primary granulosa reporter assays with promoter mutations and FOXL2 siRNA","pmids":["23567549"],"confidence":"Medium","gaps":["Mechanism of FOXL2-SMAD3 antagonism on the promoter not fully resolved","Single lab reporter-based"]},{"year":2013,"claim":"Genetic epistasis revealed a stage-dependent dual role for GDF9, promoting defective folliculogenesis early but suppressing granulosa tumor initiation in the inhibin-null background.","evidence":"Inha−/−Gdf9−/− double knockout mice with follicular histology, tumor assessment, and Inhbb expression analysis","pmids":["23446452"],"confidence":"High","gaps":["Mechanism of tumor suppression by GDF9 undefined","Relationship to activin βB signaling not mechanistically dissected"]},{"year":2013,"claim":"Provided functional evidence that a human loss-of-function variant (p.R146C) impairs GDF9 secretion and SMAD2 signaling, linking GDF9 to diminished ovarian reserve.","evidence":"Mutagenesis with secretion Western blot, human granulosa proliferation, Smad2 phosphorylation, and structural modeling","pmids":["23851219"],"confidence":"Medium","gaps":["Patient genotype-phenotype causality from a single variant","Structural prediction not experimentally validated"]},{"year":2014,"claim":"Distinguished GDF9 from BMP15 functionally, showing only BMP15 downregulates connexin43 and gap junction communication via SMAD1/5/8, whereas GDF9 does not.","evidence":"Human granulosa cell GJIC assays with Smad4 siRNA and BMP type I receptor inhibitor","pmids":["24413384"],"confidence":"Medium","gaps":["Does not address GDF9-specific roles in gap junctions","Single lab"]},{"year":2014,"claim":"Systematically established the proregion–mature domain affinity as the human disease-relevant switch, with POF-associated prodomain mutations activating GDF9 and other variants abrogating expression.","evidence":"Mutagenesis of multiple variants in HEK293T with granulosa bioassay and structural modeling","pmids":["24438375"],"confidence":"High","gaps":["In vivo consequence of constitutive activation not modeled","Structural models not experimentally confirmed"]},{"year":2014,"claim":"Linked a GDF9 promoter tandem duplication disrupting NOBOX-binding and E-box elements to primary ovarian insufficiency.","evidence":"Array CGH, PCR breakpoint mapping, and MLPA in a POI patient","pmids":["24939957"],"confidence":"Low","gaps":["No functional experiments confirming altered promoter activity were performed","Single patient observation"]},{"year":2015,"claim":"Connected GDF9 promoter activation to human fetal ovarian development, identifying a fetal NOBOX isoform that upregulates GDF9 and transient pre-follicular GDF9 expression.","evidence":"Human fetal ovary immunohistochemistry, qRT-PCR, and reporter assay with a novel NOBOX isoform","pmids":["25790371"],"confidence":"Medium","gaps":["In vivo requirement of the fetal isoform untested","Functional consequence of pre-follicular GDF9 unclear"]},{"year":2017,"claim":"Showed human BMP15 disease variants reduce BMP15/GDF9 synergy, reinforcing the GDF9-BMP15 interaction as central to human ovarian physiology.","evidence":"Mutagenesis of multiple BMP15 variants with granulosa bioassays and synergy assays","pmids":["28359091"],"confidence":"Medium","gaps":["Direct interaction interface of synergy-disrupting variants not mapped","Single lab"]},{"year":2017,"claim":"Revised the model of the secreted ligand, demonstrating native ovine/bovine GDF9 and BMP15 are predominantly monomeric promature proteins rather than dimers or heterodimers.","evidence":"Western blot with monoclonal antibodies under non-reducing/reducing/cross-linking conditions on native oocyte secretions plus in silico modeling","pmids":["28733348"],"confidence":"Medium","gaps":["How monomeric forms assemble at receptors not experimentally resolved","Species generalization to human not directly tested"]},{"year":2010,"claim":"Extended GDF9 signaling beyond the ovary, showing it promotes prostate cancer invasion and EMT through ALK5.","evidence":"GDF9 overexpression, knockdown, and recombinant protein in PC-3 cells with invasion assays and ALK5 inhibitor","pmids":["21116689"],"confidence":"Medium","gaps":["Source of GDF9 in prostate tumors not defined","Single cell line, single lab"]},{"year":2010,"claim":"Demonstrated a conserved role in gonadal sex differentiation, with zebrafish Gdf9 suppressing amh and promoting ovarian fate.","evidence":"Recombinant Gdf9 on gonadal cells with RT-qPCR and vivo-morpholino knockdown sex ratio phenotype","pmids":["28203731"],"confidence":"Medium","gaps":["Receptor pathway in zebrafish not mapped","Relevance to mammalian sex determination unclear"]},{"year":2021,"claim":"Identified a pro-survival mechanism, showing GDF9 reduces follicular apoptosis and activates primordial follicles via PI3K/Akt/FOXO3a.","evidence":"Ovine cortical slice culture with recombinant GDF9, PI3K inhibitor, and p-Akt/p-FOXO3a immunohistochemistry","pmids":["33409876"],"confidence":"Medium","gaps":["Direct receptor coupling to PI3K not shown","Single lab, ex vivo model"]},{"year":2022,"claim":"Characterized native human GDF9/BMP15 secretion dynamics during oocyte maturation, showing GDF9 dominates over BMP15 and signaling components are upregulated at MII.","evidence":"Western blot, ELISA of spent IVM media, and RT-qPCR of cumulus cell signaling genes from human oocytes","pmids":["35986324"],"confidence":"Medium","gaps":["Causal role of declining homodimer levels in maturation not tested","Correlative signaling-gene readout"]},{"year":null,"claim":"The structural basis of the active GDF9/BMP15 receptor-engaging complex and how proregion-gated latency is physiologically relieved in vivo remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No experimental structure of the GDF9-BMP15-receptor assembly","Mechanism that activates latent human GDF9 in the follicle unknown","Whether monomeric promature forms are the obligate signaling species not settled"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[2,4,5,9]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,5]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,9,17,24]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,5,21]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[3,13,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,23]}],"complexes":[],"partners":["BMP15","TGFBR1","BMPR2","ACVR1B","ACVR1C"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O60383","full_name":"Growth/differentiation factor 9","aliases":[],"length_aa":454,"mass_kda":51.4,"function":"Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/O60383/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GDF9","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GDF9","total_profiled":1310},"omim":[{"mim_id":"618014","title":"PREMATURE OVARIAN FAILURE 14; POF14","url":"https://www.omim.org/entry/618014"},{"mim_id":"612601","title":"RET FINGER PROTEIN-LIKE 4A; RFPL4A","url":"https://www.omim.org/entry/612601"},{"mim_id":"610934","title":"NOBOX OOGENESIS HOMEOBOX; NOBOX","url":"https://www.omim.org/entry/610934"},{"mim_id":"609189","title":"ANTI-SILENCING FUNCTION 1A HISTONE CHAPERONE; ASF1A","url":"https://www.omim.org/entry/609189"},{"mim_id":"608832","title":"GREMLIN 2, DAN FAMILY BMP ANTAGONIST; GREM2","url":"https://www.omim.org/entry/608832"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"epididymis","ntpm":3.4},{"tissue":"testis","ntpm":6.6}],"url":"https://www.proteinatlas.org/search/GDF9"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O60383","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60383","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60383-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60383-F1-predicted_aligned_error_v6.png","plddt_mean":66.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GDF9","jax_strain_url":"https://www.jax.org/strain/search?query=GDF9"},"sequence":{"accession":"O60383","fasta_url":"https://rest.uniprot.org/uniprotkb/O60383.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60383/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60383"}},"corpus_meta":[{"pmid":"14627550","id":"PMC_14627550","title":"Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries).","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14627550","citation_count":485,"is_preprint":false},{"pmid":"18045843","id":"PMC_18045843","title":"Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18045843","citation_count":303,"is_preprint":false},{"pmid":"15531364","id":"PMC_15531364","title":"Synergistic roles of BMP15 and GDF9 in the development and function of the oocyte-cumulus cell complex in mice: genetic evidence for an oocyte-granulosa cell regulatory loop.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15531364","citation_count":284,"is_preprint":false},{"pmid":"21226076","id":"PMC_21226076","title":"Integral role of GDF-9 and BMP-15 in ovarian function.","date":"2011","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/21226076","citation_count":266,"is_preprint":false},{"pmid":"16645022","id":"PMC_16645022","title":"Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure.","date":"2006","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16645022","citation_count":202,"is_preprint":false},{"pmid":"30039232","id":"PMC_30039232","title":"GDF-9 and BMP-15 direct the follicle symphony.","date":"2018","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30039232","citation_count":152,"is_preprint":false},{"pmid":"21198974","id":"PMC_21198974","title":"The role of oocyte-secreted factors GDF9 and BMP15 in follicular development and oogenesis.","date":"2010","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/21198974","citation_count":135,"is_preprint":false},{"pmid":"15189828","id":"PMC_15189828","title":"Spatio-temporal expression of the germ cell marker genes MATER, ZAR1, GDF9, BMP15,andVASA in adult bovine tissues, oocytes, and preimplantation embryos.","date":"2004","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/15189828","citation_count":129,"is_preprint":false},{"pmid":"25139161","id":"PMC_25139161","title":"Increased GDF9 and BMP15 mRNA levels in cumulus granulosa cells correlate with oocyte maturation, fertilization, and embryo quality in humans.","date":"2014","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/25139161","citation_count":114,"is_preprint":false},{"pmid":"29544636","id":"PMC_29544636","title":"Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function.","date":"2018","source":"Vitamins and hormones","url":"https://pubmed.ncbi.nlm.nih.gov/29544636","citation_count":107,"is_preprint":false},{"pmid":"17959852","id":"PMC_17959852","title":"Growth differentiation factor 9 (GDF9) stimulates proliferation and inhibits steroidogenesis by bovine theca cells: influence of follicle size on responses to GDF9.","date":"2007","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17959852","citation_count":106,"is_preprint":false},{"pmid":"15515056","id":"PMC_15515056","title":"Expression of growth differentiation factor 9 (GDF9), bone morphogenetic protein 15 (BMP15), and BMP receptors in the ovaries of goats.","date":"2005","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/15515056","citation_count":103,"is_preprint":false},{"pmid":"10612437","id":"PMC_10612437","title":"Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9B.","date":"1999","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10612437","citation_count":100,"is_preprint":false},{"pmid":"15271472","id":"PMC_15271472","title":"Physiology of GDF9 and BMP15 signalling molecules.","date":"2004","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/15271472","citation_count":99,"is_preprint":false},{"pmid":"19713444","id":"PMC_19713444","title":"Homozygosity for a single base-pair mutation in the oocyte-specific GDF9 gene results in sterility in Thoka sheep.","date":"2009","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19713444","citation_count":96,"is_preprint":false},{"pmid":"15917343","id":"PMC_15917343","title":"The art and artifact of GDF9 activity: cumulus expansion and the cumulus expansion-enabling factor.","date":"2005","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/15917343","citation_count":87,"is_preprint":false},{"pmid":"21047911","id":"PMC_21047911","title":"Estrogen promotes the development of mouse cumulus cells in coordination with oocyte-derived GDF9 and BMP15.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21047911","citation_count":85,"is_preprint":false},{"pmid":"21496799","id":"PMC_21496799","title":"Influence of follicular fluid GDF9 and BMP15 on embryo quality.","date":"2011","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/21496799","citation_count":83,"is_preprint":false},{"pmid":"30060157","id":"PMC_30060157","title":"Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells.","date":"2018","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30060157","citation_count":80,"is_preprint":false},{"pmid":"19359354","id":"PMC_19359354","title":"Temporal regulation of BMP2, BMP6, BMP15, GDF9, BMPR1A, BMPR1B, BMPR2 and TGFBR1 mRNA expression in the oocyte, granulosa and theca cells of developing preovulatory follicles in the pig.","date":"2009","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19359354","citation_count":79,"is_preprint":false},{"pmid":"12912906","id":"PMC_12912906","title":"GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12912906","citation_count":79,"is_preprint":false},{"pmid":"20528846","id":"PMC_20528846","title":"A new polymorphism in the Growth and Differentiation Factor 9 (GDF9) gene is associated with increased ovulation rate and prolificacy in homozygous sheep.","date":"2011","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20528846","citation_count":76,"is_preprint":false},{"pmid":"16997917","id":"PMC_16997917","title":"Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16997917","citation_count":75,"is_preprint":false},{"pmid":"21632818","id":"PMC_21632818","title":"Growth differentiating factor 9 (GDF9) and bone morphogenetic protein 15 both activate development of human primordial follicles in vitro, with seemingly more beneficial effects of GDF9.","date":"2011","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21632818","citation_count":75,"is_preprint":false},{"pmid":"30414564","id":"PMC_30414564","title":"Two strongly linked single nucleotide polymorphisms (Q320P and V397I) in GDF9 gene are associated with litter size in cashmere goats.","date":"2018","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/30414564","citation_count":73,"is_preprint":false},{"pmid":"15380806","id":"PMC_15380806","title":"Are BMP-15 and GDF-9 primary determinants of ovulation quota in mammals?","date":"2004","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/15380806","citation_count":71,"is_preprint":false},{"pmid":"21911477","id":"PMC_21911477","title":"Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15.","date":"2011","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/21911477","citation_count":71,"is_preprint":false},{"pmid":"18633140","id":"PMC_18633140","title":"The proregion of mouse BMP15 regulates the cooperative interactions of BMP15 and GDF9.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18633140","citation_count":68,"is_preprint":false},{"pmid":"17482612","id":"PMC_17482612","title":"Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure.","date":"2007","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/17482612","citation_count":66,"is_preprint":false},{"pmid":"17093201","id":"PMC_17093201","title":"The effects of immunizing sheep with different BMP15 or GDF9 peptide sequences on ovarian follicular activity and ovulation rate.","date":"2006","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17093201","citation_count":62,"is_preprint":false},{"pmid":"24413384","id":"PMC_24413384","title":"Oocyte-derived BMP15 but not GDF9 down-regulates connexin43 expression and decreases gap junction intercellular communication activity in immortalized human granulosa cells.","date":"2014","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/24413384","citation_count":61,"is_preprint":false},{"pmid":"15607004","id":"PMC_15607004","title":"A deletion mutation in GDF9 in sisters with spontaneous DZ twins.","date":"2004","source":"Twin research : the official journal of the International Society for Twin Studies","url":"https://pubmed.ncbi.nlm.nih.gov/15607004","citation_count":56,"is_preprint":false},{"pmid":"20020203","id":"PMC_20020203","title":"Polymorphism of BMPR1B, BMP15 and GDF9 fecundity genes in prolific Garole sheep.","date":"2009","source":"Tropical animal health and production","url":"https://pubmed.ncbi.nlm.nih.gov/20020203","citation_count":54,"is_preprint":false},{"pmid":"20857181","id":"PMC_20857181","title":"Expression of GDF-9, BMP-15 and their receptors in mammalian ovary follicles.","date":"2010","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/20857181","citation_count":53,"is_preprint":false},{"pmid":"25172094","id":"PMC_25172094","title":"Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome.","date":"2014","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25172094","citation_count":52,"is_preprint":false},{"pmid":"28203731","id":"PMC_28203731","title":"Expression analysis of growth differentiation factor 9 (Gdf9/gdf9), anti-müllerian hormone (Amh/amh) and aromatase (Cyp19a1a/cyp19a1a) during gonadal differentiation of the zebrafish, Danio rerio.","date":"2017","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/28203731","citation_count":51,"is_preprint":false},{"pmid":"23851219","id":"PMC_23851219","title":"Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women.","date":"2013","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23851219","citation_count":50,"is_preprint":false},{"pmid":"17715428","id":"PMC_17715428","title":"Patterns of expression of messenger RNAs encoding GDF9, BMP15, TGFBR1, BMPR1B, and BMPR2 during follicular development and characterization of ovarian follicular populations in ewes carrying the Woodlands FecX2W mutation.","date":"2007","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/17715428","citation_count":50,"is_preprint":false},{"pmid":"28359091","id":"PMC_28359091","title":"BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9.","date":"2017","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28359091","citation_count":48,"is_preprint":false},{"pmid":"31607184","id":"PMC_31607184","title":"The role of BMP15 and GDF9 in the pathogenesis of primary ovarian insufficiency.","date":"2019","source":"Human fertility (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31607184","citation_count":43,"is_preprint":false},{"pmid":"24939957","id":"PMC_24939957","title":"Identification of a duplication within the GDF9 gene and novel candidate genes for primary ovarian insufficiency (POI) by a customized high-resolution array comparative genomic hybridization platform.","date":"2014","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24939957","citation_count":40,"is_preprint":false},{"pmid":"25790371","id":"PMC_25790371","title":"GDF9 is transiently expressed in oocytes before follicle formation in the human fetal ovary and is regulated by a novel NOBOX transcript.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25790371","citation_count":39,"is_preprint":false},{"pmid":"21474603","id":"PMC_21474603","title":"Signalling pathways involved in the cooperative effects of ovine and murine GDF9+BMP15-stimulated thymidine uptake by rat granulosa cells.","date":"2011","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21474603","citation_count":39,"is_preprint":false},{"pmid":"22357543","id":"PMC_22357543","title":"DAN (NBL1) specifically antagonizes BMP2 and BMP4 and modulates the actions of GDF9, BMP2, and BMP4 in the rat ovary.","date":"2012","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/22357543","citation_count":38,"is_preprint":false},{"pmid":"19480014","id":"PMC_19480014","title":"Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.","date":"2009","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/19480014","citation_count":36,"is_preprint":false},{"pmid":"29587293","id":"PMC_29587293","title":"Effects of MiR-375-BMPR2 as a Key Factor Downstream of BMP15/GDF9 on the Smad1/5/8 and Smad2/3 Signaling Pathways.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29587293","citation_count":35,"is_preprint":false},{"pmid":"22234469","id":"PMC_22234469","title":"Activation of latent human GDF9 by a single residue change (Gly 391 Arg) in the mature domain.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22234469","citation_count":35,"is_preprint":false},{"pmid":"28377898","id":"PMC_28377898","title":"BMP15 and GDF9 Gene Mutations in Premature Ovarian Failure.","date":"2017","source":"Journal of reproduction & infertility","url":"https://pubmed.ncbi.nlm.nih.gov/28377898","citation_count":34,"is_preprint":false},{"pmid":"30033985","id":"PMC_30033985","title":"GDF9 and BMP15 induce development of antrum-like structures by bovine granulosa cells without oocytes.","date":"2018","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/30033985","citation_count":33,"is_preprint":false},{"pmid":"32659273","id":"PMC_32659273","title":"Growth differentiation factor 9 (gdf9) and bone morphogenetic protein 15 (bmp15) are potential intraovarian regulators of steroidogenesis in Japanese flounder (Paralichthys olivaceus).","date":"2020","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32659273","citation_count":33,"is_preprint":false},{"pmid":"19144040","id":"PMC_19144040","title":"Polymorphisms in GDF9 and BMP15 associated with fertility and ovulation rate in Moghani and Ghezel sheep in Iran.","date":"2009","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/19144040","citation_count":33,"is_preprint":false},{"pmid":"28214889","id":"PMC_28214889","title":"Regulatory Role of miRNA-375 in Expression of BMP15/GDF9 Receptors and its Effect on Proliferation and Apoptosis of Bovine Cumulus Cells.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28214889","citation_count":33,"is_preprint":false},{"pmid":"30274220","id":"PMC_30274220","title":"Expression Analysis of the Prolific Candidate Genes, BMPR1B, BMP15, and GDF9 in Small Tail Han Ewes with Three Fecundity (FecB Gene) Genotypes.","date":"2018","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/30274220","citation_count":33,"is_preprint":false},{"pmid":"21181498","id":"PMC_21181498","title":"Polymorphisms of caprine GDF9 gene and their association with litter size in Jining Grey goats.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21181498","citation_count":32,"is_preprint":false},{"pmid":"29786687","id":"PMC_29786687","title":"Genome-wide analysis of circular RNAs in bovine cumulus cells treated with BMP15 and GDF9.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29786687","citation_count":32,"is_preprint":false},{"pmid":"25039891","id":"PMC_25039891","title":"Mutation in the protease cleavage site of GDF9 increases ovulation rate and litter size in heterozygous ewes and causes infertility in homozygous ewes.","date":"2014","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25039891","citation_count":31,"is_preprint":false},{"pmid":"35511085","id":"PMC_35511085","title":"Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.","date":"2022","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35511085","citation_count":30,"is_preprint":false},{"pmid":"22812579","id":"PMC_22812579","title":"Polymorphism identification in goat GNRH1 and GDF9 genes and their association analysis with litter size.","date":"2012","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22812579","citation_count":30,"is_preprint":false},{"pmid":"33397408","id":"PMC_33397408","title":"Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders.","date":"2021","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/33397408","citation_count":30,"is_preprint":false},{"pmid":"26474685","id":"PMC_26474685","title":"Quantitative expression patterns of GDF9 and BMP15 genes in sheep ovarian follicles grown in vivo or cultured in vitro.","date":"2015","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/26474685","citation_count":30,"is_preprint":false},{"pmid":"19007555","id":"PMC_19007555","title":"Expression pattern of zygote arrest 1 (ZAR1), maternal antigen that embryo requires (MATER), growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) genes in ovine oocytes and in vitro-produced preimplantation embryos.","date":"2008","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/19007555","citation_count":30,"is_preprint":false},{"pmid":"17453295","id":"PMC_17453295","title":"The role of growth differentiation factor-9 (GDF-9) and its analog, GDF-9b/BMP-15, in human breast cancer.","date":"2007","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17453295","citation_count":30,"is_preprint":false},{"pmid":"34687940","id":"PMC_34687940","title":"miR-23b-3p inhibits chicken granulosa cell proliferation and steroid hormone synthesis via targeting GDF9.","date":"2021","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/34687940","citation_count":29,"is_preprint":false},{"pmid":"22825968","id":"PMC_22825968","title":"Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation.","date":"2012","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22825968","citation_count":29,"is_preprint":false},{"pmid":"24438375","id":"PMC_24438375","title":"Aberrant GDF9 expression and activation are associated with common human ovarian disorders.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24438375","citation_count":28,"is_preprint":false},{"pmid":"23583795","id":"PMC_23583795","title":"Association of BMPR-1B and GDF9 genes polymorphisms and secondary protein structure changes with reproduction traits in Mehraban ewes.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23583795","citation_count":28,"is_preprint":false},{"pmid":"28733348","id":"PMC_28733348","title":"Molecular forms of ruminant BMP15 and GDF9 and putative interactions with receptors.","date":"2017","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28733348","citation_count":27,"is_preprint":false},{"pmid":"38999341","id":"PMC_38999341","title":"The Roles of GDF-9, BMP-15, BMP-4 and EMMPRIN in Folliculogenesis and In Vitro Fertilization.","date":"2024","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38999341","citation_count":27,"is_preprint":false},{"pmid":"21184179","id":"PMC_21184179","title":"GDF9 as a candidate gene for prolificacy of Small Tail Han sheep.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21184179","citation_count":27,"is_preprint":false},{"pmid":"32235645","id":"PMC_32235645","title":"Novel Variants in GDF9 Gene Affect Promoter Activity and Litter Size in Mongolia Sheep.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32235645","citation_count":26,"is_preprint":false},{"pmid":"23581245","id":"PMC_23581245","title":"Differential ovarian morphometry and follicular expression of BMP15, GDF9 and BMPR1B influence the prolificacy in goat.","date":"2013","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/23581245","citation_count":26,"is_preprint":false},{"pmid":"21291886","id":"PMC_21291886","title":"Exogenous GDF9 but not Activin A, BMP15 or TGFβ alters tight junction protein transcript abundance in zebrafish ovarian follicles.","date":"2011","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21291886","citation_count":26,"is_preprint":false},{"pmid":"33671790","id":"PMC_33671790","title":"Polymorphism Detection of GDF9 Gene and Its Association with Litter Size in Luzhong Mutton Sheep (Ovis aries).","date":"2021","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/33671790","citation_count":25,"is_preprint":false},{"pmid":"23764009","id":"PMC_23764009","title":"Importance of the GDF9 signaling pathway on cumulus cell expansion and oocyte competency in sheep.","date":"2013","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/23764009","citation_count":24,"is_preprint":false},{"pmid":"31683597","id":"PMC_31683597","title":"Genetic Effects of Single Nucleotide Polymorphisms in the Goat GDF9 Gene on Prolificacy: True or False Positive?","date":"2019","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/31683597","citation_count":23,"is_preprint":false},{"pmid":"35986324","id":"PMC_35986324","title":"Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM.","date":"2022","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/35986324","citation_count":23,"is_preprint":false},{"pmid":"31211369","id":"PMC_31211369","title":"Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies.","date":"2019","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31211369","citation_count":23,"is_preprint":false},{"pmid":"15519042","id":"PMC_15519042","title":"Differential expression of bone morphogenetic protein 4-6 (BMP-4, -5, and -6) and growth differentiation factor-9 (GDF-9) during ovarian development in neonatal pigs.","date":"2004","source":"Domestic animal endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15519042","citation_count":23,"is_preprint":false},{"pmid":"22106408","id":"PMC_22106408","title":"Active immunization against the proregions of GDF9 or BMP15 alters ovulation rate and litter size in mice.","date":"2011","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22106408","citation_count":23,"is_preprint":false},{"pmid":"24751660","id":"PMC_24751660","title":"Direct evidence on the contribution of a missense mutation in GDF9 to variation in ovulation rate of Finnsheep.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24751660","citation_count":23,"is_preprint":false},{"pmid":"23439295","id":"PMC_23439295","title":"Differential expression of GDF9, TGFB1, TGFB2 and TGFB3 in porcine oocytes isolated from follicles of different size before and after culture in vitro.","date":"2013","source":"Acta veterinaria Hungarica","url":"https://pubmed.ncbi.nlm.nih.gov/23439295","citation_count":22,"is_preprint":false},{"pmid":"29696699","id":"PMC_29696699","title":"Polymorphism of GDF9 and BMPR1B genes and their association with litter size in Markhoz goats.","date":"2018","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/29696699","citation_count":21,"is_preprint":false},{"pmid":"33409876","id":"PMC_33409876","title":"Involvement of Phosphorylated Akt and FOXO3a in the Effects of Growth and Differentiation Factor-9 (GDF-9) on Inhibition of Follicular Apoptosis and Induction of Granulosa Cell Proliferation After In Vitro Culture of Sheep Ovarian Tissue.","date":"2021","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/33409876","citation_count":20,"is_preprint":false},{"pmid":"21116689","id":"PMC_21116689","title":"Growth and differentiation factor 9 (GDF-9) induces epithelial-mesenchymal transition in prostate cancer cells.","date":"2010","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21116689","citation_count":20,"is_preprint":false},{"pmid":"15112318","id":"PMC_15112318","title":"Bromodomain containing 2 (Brd2) is expressed in distinct patterns during ovarian folliculogenesis independent of FSH or GDF9 action.","date":"2004","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/15112318","citation_count":20,"is_preprint":false},{"pmid":"23567549","id":"PMC_23567549","title":"Granulosa cell tumor mutant FOXL2C134W suppresses GDF-9 and activin A-induced follistatin transcription in primary granulosa cells.","date":"2013","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23567549","citation_count":19,"is_preprint":false},{"pmid":"28762037","id":"PMC_28762037","title":"Genetic polymorphism of growth differentiation factor 9 (GDF9) gene related to fecundity in two Egyptian sheep breeds.","date":"2017","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28762037","citation_count":19,"is_preprint":false},{"pmid":"32223330","id":"PMC_32223330","title":"Prediction of ovarian aging using ovarian expression of BMP15, GDF9, and C-KIT.","date":"2020","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/32223330","citation_count":18,"is_preprint":false},{"pmid":"27341772","id":"PMC_27341772","title":"Temporal expression of GDF-9 and BMP-15 mRNAs in canine ovarian follicles.","date":"2016","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/27341772","citation_count":18,"is_preprint":false},{"pmid":"23849650","id":"PMC_23849650","title":"Expression of growth differentiation factor 9 (GDF-9) during in vitro maturation in canine oocytes.","date":"2013","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/23849650","citation_count":18,"is_preprint":false},{"pmid":"31392662","id":"PMC_31392662","title":"Association of BMP15 and GDF9 variants to premature ovarian insufficiency.","date":"2019","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31392662","citation_count":17,"is_preprint":false},{"pmid":"23446452","id":"PMC_23446452","title":"GDF9 modulates the reproductive and tumor phenotype of female inha-null mice.","date":"2013","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/23446452","citation_count":17,"is_preprint":false},{"pmid":"23877969","id":"PMC_23877969","title":"Anti-Müllerian hormone (AMH), inhibin-α, growth differentiation factor 9 (GDF9), and bone morphogenic protein-15 (BMP15) mRNA and protein are influenced by photoperiod-induced ovarian regression and recrudescence in Siberian hamster ovaries.","date":"2013","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/23877969","citation_count":17,"is_preprint":false},{"pmid":"26876149","id":"PMC_26876149","title":"Differential expression of GDF-9 and BMP- 15 during follicular development in canine ovaries evaluated by flow cytometry.","date":"2016","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/26876149","citation_count":17,"is_preprint":false},{"pmid":"23724366","id":"PMC_23724366","title":"Differential expression dynamics of Growth differentiation factor9 (GDF9) and Bone morphogenetic factor15 (BMP15) mRNA transcripts during in vitro maturation of buffalo (Bubalus bubalis) cumulus-oocyte complexes.","date":"2013","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/23724366","citation_count":17,"is_preprint":false},{"pmid":"28903889","id":"PMC_28903889","title":"GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome.","date":"2017","source":"Balkan medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/28903889","citation_count":16,"is_preprint":false},{"pmid":"28831646","id":"PMC_28831646","title":"Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms.","date":"2017","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28831646","citation_count":16,"is_preprint":false},{"pmid":"23912750","id":"PMC_23912750","title":"Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS.","date":"2013","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23912750","citation_count":16,"is_preprint":false},{"pmid":"32299511","id":"PMC_32299511","title":"BMPR-1B, BMP-15 and GDF-9 genes structure and their relationship with litter size in six sheep breeds reared in Egypt.","date":"2020","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/32299511","citation_count":16,"is_preprint":false},{"pmid":"23301039","id":"PMC_23301039","title":"Investigation of prolific sheep from UK and Ireland for evidence on origin of the mutations in BMP15 (FecX(G), FecX(B)) and GDF9 (FecG(H)) in Belclare and Cambridge sheep.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23301039","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54284,"output_tokens":6688,"usd":0.131586,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15730,"output_tokens":6439,"usd":0.119813,"stage2_stop_reason":"end_turn"},"total_usd":0.251399,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"GCNF (germ cell nuclear factor) directly represses GDF9 transcription by binding to DR0 elements within the GDF9 gene promoter, as shown by molecular binding studies and reporter assays in an oocyte-specific GCNF knockout mouse model.\",\n      \"method\": \"Chromatin binding assays, reporter gene assays, oocyte-specific conditional knockout mouse model\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal molecular binding to promoter DR0 elements confirmed by reporter assays and in vivo knockout model with defined phenotype\",\n      \"pmids\": [\"12912906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NOBOX transcription factor directly binds to specific NOBOX binding elements (NBEs: TAATTG, TAGTTG, TAATTA) in the Gdf9 promoter at positions -786, -967, and -1259, and augments transcriptional activity of Gdf9 in oocytes during early folliculogenesis, as confirmed by chromatin immunoprecipitation.\",\n      \"method\": \"SELEX (cyclic amplification of sequence target assay), mutation analysis, luciferase reporter assays, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods including SELEX, mutation analysis, reporter assays, and ChIP all confirming direct NOBOX binding and transcriptional activation of GDF9\",\n      \"pmids\": [\"16997917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GDF9 stimulates proliferation and inhibits steroidogenesis in bovine theca cells from small (3-6 mm) follicles, decreasing progesterone and androstenedione production, and activates SMAD2/3-mediated CAGA promoter signaling via ALK5 (TGFBR1); theca cells from large follicles show little response, correlated with lower ALK5 mRNA abundance.\",\n      \"method\": \"Primary bovine theca cell culture, [3H]-thymidine incorporation, steroid RIA, transfected SMAD reporter assay, RT-PCR\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (proliferation assay, steroid measurement, SMAD reporter, mRNA quantification) in primary cells with dose-response\",\n      \"pmids\": [\"17959852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BMP15 and GDF9 together (but not alone) control cumulus cell cholesterol biosynthesis by promoting expression of cholesterol biosynthetic enzyme transcripts (Mvk, Pmvk, Fdps, Sqle, Cyp51, Sc4mol, Ebp); oocytes are deficient in cholesterol synthesis and depend on cumulus cells for cholesterol supply via GDF9/BMP15 paracrine signaling.\",\n      \"method\": \"Bmp15−/− and Bmp15−/−Gdf9+/− double mutant mouse models, oocytectomy, wild-type oocyte co-culture rescue experiments, de novo cholesterol synthesis assays, transcript analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in multiple mutant combinations with oocytectomy rescue and biochemical cholesterol synthesis measurement\",\n      \"pmids\": [\"18045843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Recombinant mouse GDF9 is secreted as a dimer of mature protein (in both the presence and absence of BMP15), while BMP15 proregion noncovalently interacts with GDF9 mature protein (co-immunoprecipitation), forming heteromeric BMP15/GDF9 complexes; these cooperative interactions are species-specific and dependent on the BMP15 proregion, and signal through BMPR2 and ACVR1B/TGFBR1/ACVR1C receptor pathways.\",\n      \"method\": \"Co-immunoprecipitation, Western blot under non-reducing conditions, rat granulosa cell [3H]-thymidine incorporation bioassay, immunoneutralization experiments\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, receptor pathway inhibition, species-specificity tested with immunoneutralization in bioassay, multiple orthogonal methods\",\n      \"pmids\": [\"18633140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Purified mature GDF9 and BMP15 synergistically stimulate granulosa cell DNA synthesis and SMAD3 signaling; this synergy is specific (neither can be replaced by analogous TGF-β family members) and is dependent on SMAD2/3 phosphorylation, ERK1/2 (MAPK), and SRC kinase signaling pathways, but not NF-κB.\",\n      \"method\": \"Primary murine granulosa cell culture, [3H]-thymidine incorporation, SMAD3 transcriptional reporter assay, pharmacological inhibitors (SB431542, MEK/ERK inhibitor, SRC inhibitor, NF-κB inhibitor)\",\n      \"journal\": \"Molecular human reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reconstituted with purified mature proteins, multiple pathway inhibitors, specificity testing with related ligands, multiple orthogonal readouts\",\n      \"pmids\": [\"21911477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GDF9 and BMP15 synergistically activate Smad2/3 and PI3K/Akt pathways in granulosa cells to induce AMH/Amh expression by recruiting the coactivator p300 to the AMH promoter, promoting H3K27 acetylation; FSH antagonizes this via PKA/SF1-mediated induction of GIOT-1, which recruits HDAC2 to deacetylate H3K27ac and suppress AMH expression.\",\n      \"method\": \"Primary mouse granulosa cell and KGN cell line experiments, chromatin immunoprecipitation (ChIP) for p300 and H3K27ac, siRNA knockdown, Fshβ-null mouse model with FSHβ transgenic rescue, in vivo serum AMH measurement\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP with multiple histone marks, siRNA, genetic mouse models with transgenic rescue, multiple orthogonal methods in vitro and in vivo\",\n      \"pmids\": [\"30060157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Immunization of mice against the full-length GDF9 proregion increases ovulation rate (more corpora lutea) but also decreases litter size, suggesting the GDF9 proregion plays a physiologically important role in regulating ovulation rate and litter size in vivo after secretion.\",\n      \"method\": \"Active immunization of mice with GDF9 proregion peptide-KLH conjugates, ovarian histology (corpora lutea count), litter size counts\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo functional endpoint with antibody-based inhibition, single lab, two quantitative readouts\",\n      \"pmids\": [\"22106408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ovine and murine GDF9+BMP15 cooperatively stimulate granulosa cell [3H]-thymidine uptake through SMAD2/3 signaling (required for both species); ovine GDF9+BMP15 also requires NF-κB and partially p38-MAPK; murine GDF9+BMP15 requires ERK-MAPK; neither requires SMAD1/5/8 pathway. Species-specific differences in non-SMAD signaling correlate with differences in molecular complex forms detected by Western blot.\",\n      \"method\": \"Rat granulosa cell [3H]-thymidine incorporation, pharmacological pathway inhibitors, Western blot analysis of molecular complexes\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pathway inhibitors tested systematically, Western blot for molecular forms, single lab\",\n      \"pmids\": [\"21474603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Human GDF9 (hGDF9) is secreted in a latent form, whereas mouse GDF9 is active; a single residue, Gly391 in the mature domain of hGDF9 (part of the type I receptor binding site), confers latency by reducing receptor affinity. Substituting Gly391 with Arg (as in mouse GDF9) activates hGDF9 to levels comparable to mGDF9 in both adrenocortical cell luciferase assay and granulosa cell proliferation assay.\",\n      \"method\": \"Site-directed mutagenesis, adrenocortical cell luciferase reporter assay, murine granulosa cell proliferation assay, dose-response curves (EC50)\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed mutagenesis with functional validation in two independent cell-based assays, identifies single causative residue\",\n      \"pmids\": [\"22234469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GDF9 upregulates NBL1 (DAN) mRNA expression in granulosa cells; DAN specifically antagonizes BMP2 and BMP4 signaling in granulosa cells, modulating their actions during folliculogenesis; GDF9 thus indirectly establishes a BMP antagonist gradient in granulosa cells.\",\n      \"method\": \"Granulosa cell culture with recombinant GDF9, RT-PCR for NBL1 expression, cell expression system bioassays with recombinant DAN against multiple TGF-β members, progesterone production assay with BMP4 ± DAN\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional cell culture experiments with recombinant proteins and downstream steroidogenesis readout, single lab\",\n      \"pmids\": [\"22357543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The GDF9 p.R146C mutation (found in women with diminished ovarian reserve) reduces GDF9 mature protein secretion in cultured cells, decreases GDF9-stimulated granulosa cell proliferation, and impairs activation of the Smad2 pathway; structural modeling predicts disruption of an α-helix in the GDF9 proregion.\",\n      \"method\": \"Site-directed mutagenesis and expression in cultured cells, Western blot for secreted mature protein, human granulosa cell proliferation assay, Smad2 phosphorylation assay, protein structure modeling\",\n      \"journal\": \"Human reproduction (Oxford, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays (protein secretion, proliferation, Smad2 phosphorylation) for same mutant, single lab\",\n      \"pmids\": [\"23851219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In primary granulosa cells, GDF-9 (with Smad3) stimulates follistatin transcription; FOXL2 negatively regulates GDF-9-induced follistatin transcription; the granulosa cell tumor-associated mutant FOXL2C134W completely ablates GDF-9-induced follistatin expression. Both the Smad binding element and forkhead binding element in the follistatin promoter are required for GDF-9/Smad3 action.\",\n      \"method\": \"Primary granulosa cell transfection/reporter assays, siRNA knockdown of FOXL2, promoter mutation analysis\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with promoter mutations and siRNA knockdown in primary cells, single lab\",\n      \"pmids\": [\"23567549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Deletion of Gdf9 from inhibin-null (Inha−/−) mice rescues initial granulosa cell/oocyte growth defects at early follicle stages in Inha−/− ovaries, normalizes granulosa-oocyte growth dynamics, and reduces levels of Inhbb (activin βB subunit) that are upregulated in Inha−/−. However, Gdf9 deletion enhances onset of pre-tumor lesions in young mice, indicating GDF9 has a sequential role: promoting defective folliculogenesis early but suppressing tumor initiation.\",\n      \"method\": \"Inha−/− Gdf9−/− double knockout mouse model, histological analysis of follicle stages, tumor assessment, gene expression analysis\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double knockout epistasis with defined follicular and tumor phenotypes, mechanistically separates GDF9's roles at different stages\",\n      \"pmids\": [\"23446452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Oocyte-derived BMP15, but not GDF9, down-regulates connexin43 (Cx43) expression and decreases gap junction intercellular communication (GJIC) activity in human granulosa cells via Smad1/5/8 phosphorylation and a Smad4-dependent pathway (blocked by dorsomorphin, a BMP type I receptor inhibitor, and Smad4 siRNA). GDF9 did not affect Cx43 or GJIC.\",\n      \"method\": \"Human granulosa cell line (SVOG) and primary human granulosa-lutein cells, Cx43 mRNA/protein measurement, GJIC functional assay, siRNA knockdown of Smad4, pharmacological inhibition of BMP type I receptor\",\n      \"journal\": \"Molecular human reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway dissection with siRNA and pharmacological inhibitor, functional GJIC assay in primary and immortalized human cells, single lab\",\n      \"pmids\": [\"24413384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Multiple human GDF9 prodomain mutations associated with premature ovarian failure (S186Y, V216M, T238A) result in activation of hGDF9 by reducing the affinity of the prodomain for mature hGDF9, allowing it to more readily signal. Two mutations found in mothers of dizygotic twins (P103S, P374L) completely abrogate GDF9 expression. These were identified by site-directed mutagenesis and in vitro granulosa cell proliferation bioassays.\",\n      \"method\": \"Site-directed mutagenesis, expression in HEK293T cells, Western blot for mature protein, in vitro granulosa cell proliferation bioassay, homology structural modeling\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — systematic mutagenesis of 14 variants with functional bioassay validation, mechanistic explanation from structural modeling, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"24438375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Multiple BMP15 mutations associated with primary ovarian insufficiency reduce mature BMP15 protein production, BMP15 activity on granulosa cells, or the synergistic activity of BMP15 with GDF9; three variants (R68W, F194S, N196K) specifically reduce BMP15/GDF9 synergy, suggesting the GDF9-BMP15 interaction is central to human ovarian physiology.\",\n      \"method\": \"Site-directed mutagenesis, expression assays for protein production, granulosa cell bioassays, GDF9/BMP15 synergy assays\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic functional characterization of 10 mutants, single lab with multiple assay types\",\n      \"pmids\": [\"28359091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The major oocyte-secreted molecular forms of ovine and bovine BMP15 and GDF9 are cleaved and uncleaved monomeric promature proteins (not dimers or heterodimers under native conditions), as determined by Western blot with specific monoclonal antibodies under non-reducing, reducing, and cross-linking conditions; in silico modelling proposes monomeric forms interact with type II and type I receptors to initiate synergistic signaling.\",\n      \"method\": \"Western blot with monoclonal antibodies (non-reducing, reducing, reducing+cross-linking conditions), recombinant protein controls including cysteine mutants and heterodimer, isolated oocyte in vitro secretion, in silico structural modelling\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rigorous biochemical characterization with multiple antibodies and gel conditions on native oocyte secretions, single lab\",\n      \"pmids\": [\"28733348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GDF9 promotes invasiveness of prostate cancer PC-3 cells and induces epithelial-mesenchymal transition (EMT) markers (SNAI1, RhoC, ROCK-1, N-cadherin upregulation; E-cadherin downregulation); this effect is dependent on ALK-5 (activin-like kinase 5) signaling, as demonstrated by ALK-5 inhibitor treatment.\",\n      \"method\": \"GDF9 overexpression, knockdown, and recombinant GDF9 protein treatment in PC-3 cells; invasion assay; gene expression analysis; ALK-5 inhibitor pharmacological experiment\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — three independent manipulations (OE, KD, recombinant protein) with pharmacological pathway validation in cancer cell line, single lab\",\n      \"pmids\": [\"21116689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In zebrafish, recombinant Gdf9 suppresses amh expression and increases expression of activin beta subunits (inhbaa, inhbb) in somatic cells in vitro; vivo-morpholino knockdown of gdf9 causes male-skewed sex ratio, indicating GDF9 promotes oocyte/ovary differentiation partly through suppression of amh.\",\n      \"method\": \"Recombinant zebrafish Gdf9 treatment of gonadal cells in vitro, RT-qPCR gene expression, vivo-morpholino knockdown with sex ratio phenotype\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein functional assay plus morpholino in vivo knockdown, but in zebrafish model\",\n      \"pmids\": [\"28203731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GDF9 and BMP15 (exogenously supplied) induce antrum-like structure formation by bovine granulosa cells in oocytectomized complexes, and the combination is more potent than either factor alone; GDF9+BMP15 suppresses fibroblast-like differentiation of granulosa cells after oocyte removal.\",\n      \"method\": \"Bovine oocyte-granulosa cell complex culture, oocytectomy, recombinant GDF9 and BMP15 treatment, morphological assessment\",\n      \"journal\": \"The Journal of reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional cell culture with recombinant proteins and oocytectomy model, morphological readout only, single lab\",\n      \"pmids\": [\"30033985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GDF-9 reduces follicular apoptosis and promotes granulosa cell proliferation in ovine preantral follicles via the PI3K/Akt/FOXO3a pathway; LY294002 (PI3K inhibitor) blocks GDF-9-induced primordial follicle activation and reduces p-Akt immunostaining, while GDF-9 treatment maintains nuclear exclusion of p-FOXO3a.\",\n      \"method\": \"In vitro culture of ovine ovarian cortical slices with recombinant GDF-9, PI3K inhibitor (LY294002), immunohistochemistry for p-Akt and p-FOXO3a, apoptosis and proliferation assays\",\n      \"journal\": \"Reproductive sciences (Thousand Oaks, Calif.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway inhibition with two downstream signaling readouts, single lab\",\n      \"pmids\": [\"33409876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A tandem duplication of 475 bp containing part of the GDF9 gene promoter region (including three NOBOX-binding elements and an E-box) was identified in a woman with primary ovarian insufficiency, suggesting that disruption of these regulatory elements in the GDF9 promoter is causative of POI.\",\n      \"method\": \"Array comparative genomic hybridization (CGH), PCR breakpoint characterization, MLPA probe development for confirmation\",\n      \"journal\": \"Human reproduction (Oxford, England)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — structural genomic finding without functional experiments confirming promoter activity change; authors note no functional experiments were performed\",\n      \"pmids\": [\"24939957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A novel NOBOX isoform expressed in the human fetal ovary is capable of upregulating the GDF9 promoter in reporter assays; GDF9 protein is transiently expressed in oocytes before follicle formation during human fetal ovarian development.\",\n      \"method\": \"Immunohistochemistry in human fetal ovary sections, qRT-PCR, luciferase reporter assay with novel NOBOX isoform\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with novel identified NOBOX isoform plus localization immunohistochemistry in human tissue, single lab\",\n      \"pmids\": [\"25790371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Native human pro-mature GDF9 (~47 kDa) and BMP15 (~43 kDa) are detected in human oocytes by Western blot; GDF9 and BMP15 are secreted by oocytes during IVM, with GDF9 concentrations ~10-fold higher than BMP15; concentrations of both GDF9 and BMP15 homodimers are significantly lower in spent media from MII oocytes than GV oocytes; BMPR2, SMAD3, and SMAD5 are upregulated in cumulus cells from MII oocytes, indicating active GDF9/BMP15 signaling during meiotic resumption.\",\n      \"method\": \"Western blot, immunofluorescence, ELISA of spent IVM media (GDF9, BMP15, heterodimer), RT-qPCR for signaling pathway genes in cumulus cells\",\n      \"journal\": \"Reproductive biology and endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Western blot, ELISA, qPCR), native human oocyte material, single lab\",\n      \"pmids\": [\"35986324\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GDF9 is an oocyte-secreted TGF-β superfamily member that signals through ALK5 (TGFBR1)/SMAD2/3 pathways to drive granulosa and cumulus cell proliferation, cholesterol biosynthesis, and antrum formation; its transcription is directly regulated by NOBOX (activating) and GCNF (repressing) via promoter binding; human GDF9 is secreted as a latent promature monomer (rendered active by a single Gly391Arg substitution that increases receptor affinity), and its cooperative/synergistic signaling with BMP15 depends on SMAD3, ERK1/2, and SRC kinase pathways and involves non-covalent heteromeric interactions that are species-specific and influenced by the BMP15 proregion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GDF9 is an oocyte-secreted TGF-β superfamily ligand that drives follicular somatic cell proliferation and differentiation through type I receptor ALK5 (TGFBR1) and SMAD2/3 signaling [#2]. Its transcription is directly controlled at the oocyte promoter by opposing factors: NOBOX activates GDF9 by binding defined NOBOX-binding elements, while germ cell nuclear factor (GCNF) represses it through DR0 elements [#1, #0]. Acting cooperatively with the related oocyte ligand BMP15, GDF9 synergistically stimulates granulosa cell DNA synthesis and SMAD3 signaling in a manner dependent on SMAD2/3, ERK1/2 (MAPK), and SRC kinase pathways, with non-SMAD pathway requirements differing between species [#5, #8]. This GDF9/BMP15 paracrine axis programs cumulus cell metabolism — inducing cholesterol biosynthetic enzymes that supply the cholesterol-deficient oocyte — and orchestrates antrum formation and somatic gene expression including AMH, which it induces by recruiting p300 to the AMH promoter to deposit H3K27 acetylation [#3, #20, #6]. GDF9 also shapes the follicular signaling environment by inducing the BMP antagonist NBL1/DAN and follistatin transcription, and promotes follicle survival through PI3K/Akt/FOXO3a signaling [#10, #12, #21]. Human GDF9 is secreted as a latent promature protein whose activity is gated by the proregion's affinity for the mature domain; a single mature-domain residue (Gly391) confers latency, and substitution to Arg activates it [#9, #17]. The interaction between the prodomain and mature domain is central to human ovarian physiology: prodomain mutations that reduce this affinity activate GDF9, expression-abrogating variants associate with dizygotic twinning, and loss-of-function variants (e.g. p.R146C) cause premature ovarian failure and diminished ovarian reserve [#15, #11].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established how GDF9 transcription is restrained in oocytes, identifying GCNF as a direct repressor acting through promoter DR0 elements.\",\n      \"evidence\": \"Chromatin binding and reporter assays with an oocyte-specific GCNF conditional knockout mouse\",\n      \"pmids\": [\"12912906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not establish the activating side of the promoter switch\", \"Repression dynamics across follicle stages not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified NOBOX as the direct transcriptional activator of Gdf9, defining the positive arm of oocyte-specific GDF9 promoter control during early folliculogenesis.\",\n      \"evidence\": \"SELEX, mutation analysis, luciferase reporter assays, and ChIP for NOBOX binding elements in the Gdf9 promoter\",\n      \"pmids\": [\"16997917\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Combinatorial logic with GCNF repression not directly tested\", \"In vivo contribution of each NBE not dissected\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the GDF9 receptor/SMAD pathway and a cell-context-dependent response, showing GDF9 signals via ALK5/SMAD2/3 to drive theca cell proliferation while inhibiting steroidogenesis.\",\n      \"evidence\": \"Primary bovine theca cell proliferation and steroid assays, SMAD CAGA reporter, ALK5 mRNA correlation\",\n      \"pmids\": [\"17959852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking ALK5 abundance to follicle-size-dependent responsiveness not resolved\", \"Type II receptor identity not addressed here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed a metabolic function for the oocyte ligands, showing GDF9 and BMP15 together program cumulus cells to synthesize cholesterol that the oocyte cannot make itself.\",\n      \"evidence\": \"Bmp15/Gdf9 mutant mouse models with oocytectomy rescue and de novo cholesterol synthesis assays\",\n      \"pmids\": [\"18045843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional mechanism on cholesterol enzyme genes not defined\", \"Relative contribution of GDF9 vs BMP15 not separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterized the molecular basis of GDF9/BMP15 cooperativity, showing heteromeric interactions involving the BMP15 proregion that are species-specific and signal through defined type II/type I receptors.\",\n      \"evidence\": \"Co-IP, non-reducing Western blot, granulosa cell bioassay, and immunoneutralization\",\n      \"pmids\": [\"18633140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the active complex unresolved\", \"Whether the complex is obligate for signaling not settled\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reconstituted the synergy with purified proteins and mapped its signaling requirements, establishing dependence on SMAD2/3, ERK1/2, and SRC but not NF-κB.\",\n      \"evidence\": \"Purified mature GDF9/BMP15 on murine granulosa cells with pathway-specific inhibitors and SMAD3 reporter\",\n      \"pmids\": [\"21911477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SRC and ERK integrate with SMAD output not mechanistically linked\", \"Receptor complex composition driving non-SMAD arms not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed species-specific non-SMAD signaling requirements, with ovine GDF9+BMP15 requiring NF-κB/p38 and murine requiring ERK, correlating with distinct molecular complex forms.\",\n      \"evidence\": \"Rat granulosa cell bioassay with pathway inhibitors and Western blot of molecular forms\",\n      \"pmids\": [\"21474603\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of species-specific complexes not resolved\", \"Single lab, single readout\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected GDF9/BMP15 signaling to chromatin regulation of AMH, showing induction via SMAD2/3 and PI3K/Akt with p300 recruitment and H3K27ac, antagonized by FSH.\",\n      \"evidence\": \"ChIP for p300 and H3K27ac, siRNA, and Fshβ-null mouse with transgenic rescue\",\n      \"pmids\": [\"30060157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SMAD binding to the AMH promoter not delineated here\", \"GDF9-only versus synergistic contribution not separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrated an in vivo regulatory role for the secreted GDF9 proregion in setting ovulation rate and litter size.\",\n      \"evidence\": \"Active immunization of mice against GDF9 proregion with corpora lutea and litter size counts\",\n      \"pmids\": [\"22106408\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism by which proregion antibody alters signaling unclear\", \"Single lab in vivo endpoint\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed GDF9 induces antrum-like structures and suppresses fibroblast-like dedifferentiation of granulosa cells, most potently with BMP15.\",\n      \"evidence\": \"Bovine oocyte-granulosa complex culture with oocytectomy and recombinant ligands, morphological readout\",\n      \"pmids\": [\"30033985\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular drivers of antrum formation not defined\", \"Morphological readout only\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified the molecular cause of human GDF9 latency, pinpointing Gly391 in the mature domain as the residue gating receptor affinity and activity.\",\n      \"evidence\": \"Site-directed mutagenesis with adrenocortical luciferase and granulosa proliferation assays, EC50 analysis\",\n      \"pmids\": [\"22234469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural detail of the receptor binding interface not solved\", \"Physiological mechanism that overcomes latency in vivo unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed GDF9 upstream of a BMP antagonist gradient, showing it upregulates NBL1/DAN which selectively antagonizes BMP2/BMP4 in granulosa cells.\",\n      \"evidence\": \"Granulosa cell culture with recombinant GDF9, RT-PCR, and DAN bioassays with steroidogenesis readout\",\n      \"pmids\": [\"22357543\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional control of NBL1 by GDF9 not shown\", \"In vivo relevance of the gradient untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined GDF9/SMAD3 regulation of follistatin and its modulation by FOXL2, including ablation by the tumor-associated FOXL2C134W mutant.\",\n      \"evidence\": \"Primary granulosa reporter assays with promoter mutations and FOXL2 siRNA\",\n      \"pmids\": [\"23567549\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of FOXL2-SMAD3 antagonism on the promoter not fully resolved\", \"Single lab reporter-based\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genetic epistasis revealed a stage-dependent dual role for GDF9, promoting defective folliculogenesis early but suppressing granulosa tumor initiation in the inhibin-null background.\",\n      \"evidence\": \"Inha−/−Gdf9−/− double knockout mice with follicular histology, tumor assessment, and Inhbb expression analysis\",\n      \"pmids\": [\"23446452\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of tumor suppression by GDF9 undefined\", \"Relationship to activin βB signaling not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided functional evidence that a human loss-of-function variant (p.R146C) impairs GDF9 secretion and SMAD2 signaling, linking GDF9 to diminished ovarian reserve.\",\n      \"evidence\": \"Mutagenesis with secretion Western blot, human granulosa proliferation, Smad2 phosphorylation, and structural modeling\",\n      \"pmids\": [\"23851219\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Patient genotype-phenotype causality from a single variant\", \"Structural prediction not experimentally validated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Distinguished GDF9 from BMP15 functionally, showing only BMP15 downregulates connexin43 and gap junction communication via SMAD1/5/8, whereas GDF9 does not.\",\n      \"evidence\": \"Human granulosa cell GJIC assays with Smad4 siRNA and BMP type I receptor inhibitor\",\n      \"pmids\": [\"24413384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not address GDF9-specific roles in gap junctions\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Systematically established the proregion–mature domain affinity as the human disease-relevant switch, with POF-associated prodomain mutations activating GDF9 and other variants abrogating expression.\",\n      \"evidence\": \"Mutagenesis of multiple variants in HEK293T with granulosa bioassay and structural modeling\",\n      \"pmids\": [\"24438375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequence of constitutive activation not modeled\", \"Structural models not experimentally confirmed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked a GDF9 promoter tandem duplication disrupting NOBOX-binding and E-box elements to primary ovarian insufficiency.\",\n      \"evidence\": \"Array CGH, PCR breakpoint mapping, and MLPA in a POI patient\",\n      \"pmids\": [\"24939957\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional experiments confirming altered promoter activity were performed\", \"Single patient observation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected GDF9 promoter activation to human fetal ovarian development, identifying a fetal NOBOX isoform that upregulates GDF9 and transient pre-follicular GDF9 expression.\",\n      \"evidence\": \"Human fetal ovary immunohistochemistry, qRT-PCR, and reporter assay with a novel NOBOX isoform\",\n      \"pmids\": [\"25790371\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement of the fetal isoform untested\", \"Functional consequence of pre-follicular GDF9 unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed human BMP15 disease variants reduce BMP15/GDF9 synergy, reinforcing the GDF9-BMP15 interaction as central to human ovarian physiology.\",\n      \"evidence\": \"Mutagenesis of multiple BMP15 variants with granulosa bioassays and synergy assays\",\n      \"pmids\": [\"28359091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct interaction interface of synergy-disrupting variants not mapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revised the model of the secreted ligand, demonstrating native ovine/bovine GDF9 and BMP15 are predominantly monomeric promature proteins rather than dimers or heterodimers.\",\n      \"evidence\": \"Western blot with monoclonal antibodies under non-reducing/reducing/cross-linking conditions on native oocyte secretions plus in silico modeling\",\n      \"pmids\": [\"28733348\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How monomeric forms assemble at receptors not experimentally resolved\", \"Species generalization to human not directly tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended GDF9 signaling beyond the ovary, showing it promotes prostate cancer invasion and EMT through ALK5.\",\n      \"evidence\": \"GDF9 overexpression, knockdown, and recombinant protein in PC-3 cells with invasion assays and ALK5 inhibitor\",\n      \"pmids\": [\"21116689\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Source of GDF9 in prostate tumors not defined\", \"Single cell line, single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated a conserved role in gonadal sex differentiation, with zebrafish Gdf9 suppressing amh and promoting ovarian fate.\",\n      \"evidence\": \"Recombinant Gdf9 on gonadal cells with RT-qPCR and vivo-morpholino knockdown sex ratio phenotype\",\n      \"pmids\": [\"28203731\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor pathway in zebrafish not mapped\", \"Relevance to mammalian sex determination unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified a pro-survival mechanism, showing GDF9 reduces follicular apoptosis and activates primordial follicles via PI3K/Akt/FOXO3a.\",\n      \"evidence\": \"Ovine cortical slice culture with recombinant GDF9, PI3K inhibitor, and p-Akt/p-FOXO3a immunohistochemistry\",\n      \"pmids\": [\"33409876\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor coupling to PI3K not shown\", \"Single lab, ex vivo model\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Characterized native human GDF9/BMP15 secretion dynamics during oocyte maturation, showing GDF9 dominates over BMP15 and signaling components are upregulated at MII.\",\n      \"evidence\": \"Western blot, ELISA of spent IVM media, and RT-qPCR of cumulus cell signaling genes from human oocytes\",\n      \"pmids\": [\"35986324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal role of declining homodimer levels in maturation not tested\", \"Correlative signaling-gene readout\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of the active GDF9/BMP15 receptor-engaging complex and how proregion-gated latency is physiologically relieved in vivo remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental structure of the GDF9-BMP15-receptor assembly\", \"Mechanism that activates latent human GDF9 in the follicle unknown\", \"Whether monomeric promature forms are the obligate signaling species not settled\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [2, 4, 5, 9]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 9, 17, 24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5, 21]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [3, 13, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 23]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMP15\", \"TGFBR1\", \"BMPR2\", \"ACVR1B\", \"ACVR1C\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}